Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
30 participants
INTERVENTIONAL
2024-04-01
2024-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Celiac Disease Prevention With Probiotics
NCT03176095
Prebiotic as a Supplement of Gluten-free Diet in the Management of Celiac Disease in Children
NCT03064997
Efficacy of Cholesterol-lowering L. Plantarum on Cardiometabolic Health Biomarkers in Coeliac Disease Patients
NCT06178107
Safety of Prolonged Administration of Triticum Monococcum in Celiac Disease
NCT02220166
Effects of a Nutritional Solution to Improve Intestinal Permeability in Celiac Patients
NCT03483805
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study will be conducted with 30 volunteers who present to the Mersin University Faculty of Medicine Hospital Gastroenterology Department in Mersin.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
People with celiac disease who eat cookies with unripe carob - Experimental Group
Individuals with celiac disease who met the inclusion criteria and participated in the study will divided into two groups by Specialist OrhN SEZGİN, and they will be asked to consume the cookies produced (in the preliminary study) produced as a standard (n=15) and with the addition of unripe carob (n=15) for eight weeks.
The individuals participating in the study will be asked not to change their eating habits, physical activity habits, and drug treatments during the study period. Each individual participating in the study will be provided with the required amount of cookie during the study and will be contacted weekly by Ecem GÜLÜŞEN, a dietitian, to verify whether they consume cookies regularly.
Unripre Carob
The standard cookies and test cookies (with carob addition) to be used in the study will be produced by Dr. Lecturer Özlem ÖZPAK AKKUŞ at Toros University Nutrition Principles Laboratory. Prof. Dr. Özlem ÖZPAK AKKUŞ will produce the cookies. For standard cookies, 1 egg, 325 g gluten-free flour (Söke flour), 75 grams butter, 50 grams sugar, 10 grams baking powder, 10 grams vanilla will be added and the prepared bread mixture will be divided into 50 equal parts. To make cookies with the addition of unripe carob, the same recipe as the standard cookie will be used to make the test cookie with the addition of unripe carob fruit flour, divided into 50 equal parts, and the amount of unripe carob fruit flour will be added by calculating the daily fiber consumption amount of the patients participating in the study to be 25 g.
No intervention - Control Group
Individuals with celiac disease will not eat unripe carob cookie
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Unripre Carob
The standard cookies and test cookies (with carob addition) to be used in the study will be produced by Dr. Lecturer Özlem ÖZPAK AKKUŞ at Toros University Nutrition Principles Laboratory. Prof. Dr. Özlem ÖZPAK AKKUŞ will produce the cookies. For standard cookies, 1 egg, 325 g gluten-free flour (Söke flour), 75 grams butter, 50 grams sugar, 10 grams baking powder, 10 grams vanilla will be added and the prepared bread mixture will be divided into 50 equal parts. To make cookies with the addition of unripe carob, the same recipe as the standard cookie will be used to make the test cookie with the addition of unripe carob fruit flour, divided into 50 equal parts, and the amount of unripe carob fruit flour will be added by calculating the daily fiber consumption amount of the patients participating in the study to be 25 g.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have not received dietary treatment by a dietitian before
* Body Mass Index value between 18.5-25.0 kg/m2,
* Who have consumed carob fruit and have not had any allergies,
* Signed the Informed Consent Form,
* Between the ages of 19 and 64,
* Who has not had gastrointestinal tract surgery,
* Without mental disorder,
* Without inflammatory disease,
* No antibiotics or probiotics for the last 1 month,
* Not taking prescription drugs and/or fiber supplements,
* Not taking vitamin, mineral supplements,
* Not during pregnancy and lactation,
* Without excessive alcohol consumption (\>2 drinks/day)
Exclusion Criteria
* Have gastrointestinal diseases other than celiac disease,
* Have previously received dietary treatment by a dietitian, following a diet other than a gluten-free diet,
* Body Mass Index values below 18.5 kg/m2 and above 25.0 kg/m2,
* Who have consumed carob fruit and have had any allergies,
* Not signing the Informed Volunteer Consent Form,
* Not between the ages of 19-64,
* Gastrointestinal tract surgery,
* With a mental disorder,
* With inflammatory disease,
* Taking antibiotics or probiotics for the last 1 month,
* Taking prescription medication and/or fiber supplements,
* Taking vitamin and mineral supplements,
* During pregnancy and lactation,
* Excessive alcohol consumption (\>2 drinks/day)
19 Years
64 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Toros University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Özlem ÖZPAK AKKUŞ
Asst.Prof.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Unripecarobinceliac
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.